Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg	100mg	Injectable concentrated solution	24,533,456 L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	298,266,862 L.L
L04AB04	ADALIREL	BioTech	Adalimumab - 40mg	40mg	Injectable solution	L.L
L01CD01	ABRAXANE	BioTech	Paclitaxel Albumin- bound - 5mg/ml	5mg/ml	Injectable powder for dispersion	17,850,751 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 80mg/4ml	80mg/4ml	Injectable concentrated solution	L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 162mg/0.9ml	162mg/0.9ml	Injectable solution	L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 200mg/10ml	200mg/10ml	Injectable concentrated solution	L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	L.L
B01AD02	ACTILYSE	BioTech	Alteplase - 50mg	50mg	Injectable dry powder for solution+diluent	100,976,426 L.L
N02CD01	AIMOVIG	BioTech	Erenumab - 70mg/ml	70mg/ml	Injectable solution	35,423,371 L.L
J06BA02	ARAGAM	BioHuman	Human normal immunoglobulin - 5g/100ml	5g/100ml	Injectable solution	40,075,575 L.L
B05AA01	ALBUKEY	BioHuman	Albumin human - 20%	20%	Injectable solution	4,863,366 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	3,240,004 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	6,353,687 L.L
B05AA01	ALBUTEIN	BioHuman	Albumin human - 20%	20%	Injectable solution	7,154,928 L.L
B05AA01	ALBUTEIN	BioHuman	Albumin human - 20%		Injectable solution	4,031,528 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	L.L
C02AB02	ALDOMET	B	Methyldopa - 250mg	250mg	Tablet, coated	644,400 L.L
C02AB02	ALDOMET	B	Methyldopa - 500mg	500mg	Tablet, coated	856,708 L.L
M05BA08	ACLASTA	B	Zoledronic acid (monohydrate) - 5mg/100ml	5mg/100ml	Injectable solution	21,075,062 L.L
V01AA	ACARIZAX 12 SQ-HDM ORAL LYOPHILISATE	B	Allergen extracts - 12 SQ-HDM		Tablet, lyophilised	9,366,451 L.L
A02AF02	ACTONORM	B	Aluminium hydroxide - 220mg/5ml, Magnesium hydroxide - 200mg/5ml, Simethicone - 25mg/5ml		Suspension	425,998 L.L
A10BG03	ACTOS	B	Pioglitazone HCl - 30mg	30mg	Tablet	2,484,765 L.L
A10BG03	ACTOS	B	Pioglitazone HCl - 15mg	15mg	Tablet	1,243,054 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 125mg/5ml, Clavulanic Acid (potassium) - 31.25mg/5ml	156.25mg/5ml	Powder for suspension	302,365 L.L
C02LA51	ADELPHAN ESIDREX	B	Reserpine - 0.1mg, Hydrochlorothiazide - 10mg, Dihydralazine - 10mg		Tablet	371,157 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 250mg/5ml, Clavulanic Acid (potassium) - 62.5mg/5ml	312.5mg/5ml	Powder for suspension	542,912 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Ointment	385,683 L.L
R05X	ACTISOUFRE	B	Sulfure de Sodium - 13mg, Saccharomyces Cerevisiae - 500mg		Solution	740,457 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Cream	385,683 L.L

...